Edesa Biotech, Inc.EDSANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank79
3Y CAGR-35.0%
5Y CAGR+2.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-35.0%/yr
vs +59.0%/yr prior
5Y CAGR
+2.0%/yr
Recent deceleration
Acceleration
-93.9pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.67M | +27.3% |
| 2024 | $2.88M | -39.9% |
| 2023 | $4.79M | -64.0% |
| 2022 | $13.34M | -25.7% |
| 2021 | $17.95M | +439.0% |
| 2020 | $3.33M | +203.7% |
| 2019 | $1.10M | -47.5% |
| 2018 | $2.09M | +5.8% |
| 2017 | $1.97M | +14.1% |
| 2016 | $1.73M | - |